Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series
Abstract Background The use of cannabis for treating fibromyalgia syndrome (FMS) has not been comprehensively investigated. Thus, we have assessed the efficacy and adverse events (AEs) of short- and long-term medical cannabis (MC) treatment for FMS. Methods Data were obtained from medical reports ar...
Main Author: | Manuela Mazza |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Journal of Cannabis Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42238-021-00060-6 |
Similar Items
-
Cannabis for the Treatment of Fibromyalgia: A Systematic Review
by: Natalie H. Strand, et al.
Published: (2023-06-01) -
Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabis/oxycodone combination—the SPIRAL study
by: Cornelis Jan van Dam, et al.
Published: (2023-01-01) -
Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry
by: Claire Wang, et al.
Published: (2023-07-01) -
Fibromyalgia in the light of different methods of treatment
by: Maciej Szota, et al.
Published: (2022-12-01) -
Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases
by: Howard Amital
Published: (2020-01-01)